March 28, 2023 News by Patricia Inacio, PhD Use of cannabis-based products tied to severity of MS disability, pain Cannabis-based products are more likely to be used byĀ multiple sclerosis (MS) patients with higher levels of disability and pain than those with lesser disability or pain,Ā according to a study of findings in Spain and France. This āmay encourage health authorities to consider relaxing the barriers to cannabis use for…
March 16, 2023 News by Mary Chapman Online medical cannabis clinic for MS pain management opens in UK The Kanabo Group has established what it claims is the U.K.ās first online medical cannabis clinic to help people with multiple sclerosis and other conditions manage chronic pain. Called Treat It, the clinic is expected to help those whose conventional pharmaceutical medicines are ineffective or those…
August 20, 2021 News by Margarida Maia, PhD Barriers Limit Sativex Access for Patients With Spasticity in UK Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity ā or muscle stiffness and spasms ā in adults with multiple sclerosis (MS), remains unavailable to many patients there, according to a report by the MS Society UK. Sativex is the only licensed…
June 7, 2021 News by Margarida Maia, PhD Medical Cannabis in Greece Will Be Sold Under Brand Name Panaxir Medical cannabis made by Panaxia Labs Israel will be marketed and distributed in Greece by Leriva Group, under a recent agreement between the two companies and pending a marketing authorization in the country. The product will be sold under the brand name Panaxir. The companies expect to start…
August 12, 2019 News by Jose Marques Lopes, PhD NICE and NHS England Oppose Sativex to Treat Spasticity in MS, Urge More Studies of Medical Cannabis A draft guidance issued by the National Institute for Health and Care Excellence (NICE), a U.K. advisory board, and a reviewĀ by Englandās National Health Service (NHS) call for more research into medical cannabis forĀ multiple sclerosisĀ and other conditions. NICE also recommended against prescribingĀ SativexĀ as a treatment for…
August 8, 2019 News by Joana Carvalho, PhD Medical Marijuana Now Available to MS and Other Patients in Louisiana Medical cannabis products, jointly developed by GB Sciences Louisiana (GBSL) and the Louisiana State University Agricultural Center‘s (LSU AgCenter)Ā Therapeutic Cannabis Program, are now available for purchase by qualified patients with illnesses that includeĀ multiple sclerosis (MS) at nine state-licensed pharmacies. The decision, announced by the Louisiana Department…
October 29, 2018 Columns by Ed Tobias MS News that Caught My Eye Last Week: Cannabis Pill, Stem Cells in Outer Space, Gut Bacteria and T-cells, Herpes and MS Stanford Researchers Open Medical Cannabis Company with Oral Therapy for MS Pain, Spasticity as Initial Goal Let’s be clear up front. There’s no indication that you’ll be able to buy a cannabis pill from this company anytime soon ā or ever. The company’s website says that testing…
July 6, 2018 News by Jose Marques Lopes, PhD Medical Cannabis Favored to Treat MS Spasticity and Other Ills by Doctors in Australia, Survey Finds Most general practitioners in Australia favor prescribing medical cannabis to treat spasticity inĀ multiple sclerosis (MS) or pain in select other diseases, but are not allowed to under current laws and say they know little about its use, according to results of a national survey. A study based on its…
March 22, 2018 News by Jose Marques Lopes, PhD Evidence Supports Safety, Effectiveness of Medical Cannabis in MS, Cancer, Other Diseases Medical cannabis is a safe and effective treatment for pain relief and should be integrated into current clinical practice, according to a new evidence overview. Benefits also include reducedĀ spasticity in multiple sclerosisĀ patients. The overview, titled āSpecial Issue: Cannabis in Medicine,” was published in the…
March 20, 2018 News by Patricia Silva, PhD GeneFo Guide Explains How Medical Cannabis Can Help MS Patients More studies are showing that medical cannabis can alleviate symptoms of multiple sclerosis (MS), according to a company that helps patients, doctors and others understand genetic conditions better. The observation came inĀ GeneFo’sĀ 2018 Guide to Clinical Effects of Medical Cannabis. Some research has suggested that cannabis strains containing…
March 5, 2018 News by Jose Marques Lopes, PhD Topical Medical Cannabis Cream Now Being Sold in Canada for Patients with MS, Other Conditions Registered patients in Canada can now purchaseĀ CanniMed Topical Cream, a product with medical cannabis oil designed to provide fast-acting relief for patients with multiple sclerosis (MS) and other conditions associated with pain and inflammation. The product is the result of a collaboration between Canada-based CanniMed Therapeutics and Avaria…
March 2, 2018 News by Patricia Silva, PhD Cannabis Science Seeking Feedback on Its New Medical Cannabis Website Cannabis ScienceĀ has created a website called iCannabinoidĀ that it hopes will become the premier online source of medical cannabis news and information. It is seeking feedback on the site so it can tweak it as need be. It hopes to hear from Ā patients, doctors, patient advocates, parents, researchers, government and…
February 20, 2018 News by Patricia Silva, PhD Medical Cannabis Found to Safely Reduce Chronic Pain in Older Patients in Study Medical cannabis was found to safely and significantly reduce chronic pain in older patients withĀ multiple sclerosis (MS)Ā and a wide range of other conditions, researchers in Israel report. Led by scientists at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical…
February 7, 2017 News by Patricia Silva, PhD 95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It Ninety-five percent ofĀ multiple sclerosis (MS)Ā patients believe medical marijuana should be a treatment option, according to aĀ GeneFoĀ online survey. The survey also showed that almost 73 percent had tried it, even though about half said they hadn’t received information from a doctor about its benefits and risks. A National…
January 18, 2017 News by Patricia Silva, PhD Majority of Irish Physicians Approve of Cannabis as MS Treatment, Survey Finds Most Irish general practitioners (GPs) are against decriminalizing cannabis use, but many, especially those over age 50, sayĀ it canĀ be useful for treating multiple sclerosis (MS) and other medical conditions, according to a recent survey. The results are detailed in the study, “Irish general practitioner attitudes toward decriminalisation…
October 25, 2016 News by Patricia Silva, PhD CannaCure Florida to Host November Medical Cannabis Education Conference in Tampa CannaCure Florida,Ā a patient-focused producer of medical cannabis and related products, will host physicians and medical professionals for a peer-to-peer medical cannabis educational conference Nov. 18 in TampaĀ to provide guidance forĀ incorporating medical cannabis into traditional medical practices. The event will be held 9 a.m. to 4:30 p.m. at the Cuban…
October 7, 2016 News by Patricia Silva, PhD Celgene Partners with Abide to Bring Cannabis-like Treatment for MS into Further Clinical Tests Abide TherapeuticsĀ announced that Celgene has opted to obtain theĀ rights, outside of the United States, to ABX-1431, Abideās endocannabinoid system modulator being developed to treat neurological diseases, including multiple sclerosis (MS), by reproducing within the body the physical benefits (minus the psychotropic effects) of cannabis. ABX-1431 is an…
September 15, 2016 News by Marina Anastasiou Montel Williams Starts Medical Cannabis Company for MS and Other Chronic Diseases Montel Williams, a Naval Academy graduate diagnosed with multiple sclerosis (MS) in 1999 , recently announced the launch of a line of high-quality medical cannabis products under the brandĀ name LenitivLabsĀ byĀ Lenitiv Scientific. The former television host and wellness advocate has been particularly vocal when it comes to supportĀ the use of medical…
June 15, 2016 Columns by admin Medical Cannabis Has a Role to Play in MS Treatment Medical cannabis is subject to laws relating to the growing, possession, transport, and use of marijuana. These vary from country to country and, in the United States, from state to state. There are also differences between marijuana for general and recreational use and for the same product for medical use.
January 11, 2016 News by Charles Moore Can Cannabinoid Chewing Gum Treat Multiple Sclerosis Pain and Spasticity? MedChew Rx, by AXIM Biotechnology,Ā the world’s first patented cannabinoid release chewing gum for pain and spasticity in multiple sclerosis (MS), is movingĀ into clinical testing. If all goes well, the company plans for a global release date ofĀ 2017. Medical cannabis is believed to have considerable promise as a therapy for…
August 24, 2015 News by Charles Moore Clinical Trials Study Cannabis Chewing Gum for MS-Associated Pain and Spasticity AXIM Biotechnologies, Inc. (AXIM)’s clinical trials testingĀ a new pharmaceutical-grade cannabis chewing gum treatment option for Multiple Sclerosis (MS) pain and spasticity are drawing lots of popular and specialty media attention, with reports in Multiple Sclerosis News Today, Marketwatch, Yahoo! Finance, Wall Street Journal, CNN Money,…